Search Result

Results for "

Chagas

" in MedChemExpress (MCE) Product Catalog:

By Targets:	AMPK (1) Angiotensin-converting Enzyme (ACE) (1) Antibiotic (3) Apoptosis (3) Autophagy (1) Bacterial (1) Casein Kinase (1) Cytochrome P450 (1) DNA/RNA Synthesis (1) Farnesyl Transferase (1) Ferroptosis (1) GSK-3 (1) HSP (1) HSV (1) IFNAR (1) Interleukin Related (1) Isotope-Labeled Compounds (1) JAK (1) NTPDase (1) p38 MAPK (1) Parasite (31) Proteasome (1) Reactive Oxygen Species (ROS) (1) Reference Standards (1) STAT (1) Syk (1) TNF Receptor (2) Topoisomerase (3)
By Research Areas:	Cancer (3) Cardiovascular Disease (2) Infection (36) Inflammation/Immunology (1) Metabolic Disease (2) Neurological Disease (1)

By Targets:

AMPK (1)

Angiotensin-converting Enzyme (ACE) (1)

Antibiotic (3)

Apoptosis (3)

Autophagy (1)

Bacterial (1)

Casein Kinase (1)

Cytochrome P450 (1)

DNA/RNA Synthesis (1)

Farnesyl Transferase (1)

Ferroptosis (1)

GSK-3 (1)

HSP (1)

HSV (1)

IFNAR (1)

Interleukin Related (1)

Isotope-Labeled Compounds (1)

JAK (1)

NTPDase (1)

p38 MAPK (1)

Parasite (31)

Proteasome (1)

Reactive Oxygen Species (ROS) (1)

Reference Standards (1)

STAT (1)

Syk (1)

TNF Receptor (2)

Topoisomerase (3)

By Research Areas:

Cancer (3)

Cardiovascular Disease (2)

Infection (36)

Inflammation/Immunology (1)

Metabolic Disease (2)

Neurological Disease (1)

Inhibitors & Agonists

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B1548

Benznidazole 3 Publications Verification Benznidazol; Ro 07-1051; Ro 71051	Parasite Antibiotic	Infection
Benznidazole (Ro 07-1051) is an antiparasitic medication, with an IC₅₀ of 20.35 μM for Colombian T. cruzi strains, and has been used in the treatment of Chagas disease .

HY-168894

CT-1	Ferroptosis JAK STAT p38 MAPK AMPK GSK-3 Apoptosis HSP TNF Receptor	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
CT-1 is a secreted protein belonging to the IL-6 cytokine family. Overexpression of CT-1 enhances cell proliferation, migration and angiogenesis via the ADMA/DDAH pathway. CT-1 inhibits the growth of triple-negative breast cancer cells by simultaneously inducing Ferroptosis in N2-type tumor-associated neutrophils and cancer cells. CT-1 activates the Jak/STAT-3, p42/p44 MAPK and AMPK pathways, and inhibits GSK-3β activity through phosphorylation to induce cardiomyocyte hypertrophy. CT-1 enhances the viability of cardiomyocytes and neurons, reduces cell Apoptosis, induces the expression of heat shock proteins (HSP) and BNP, and inhibits TNF levels. CT-1 exerts anti-tumor activity in mouse models of triple-negative breast cancer. CT-1 improves cognitive impairment in mice. CT-1 is applicable to the research of ischemic heart disease, triple-negative breast cancer, myocardial hypertrophy, Parkinson's disease, hypertensive heart disease, myocardial infarction, acute Chagas cardiomyopathy, high-fat diet-induced cognitive impairment and diabetes-related cognitive impairment .

HY-W010538

trans-4-Methylcyclohexanamine	Parasite	Infection
trans-4-Methylcyclohexanamine is an intermediate and can be used for the development of T. cruzi enzyme inhibitor .

HY-120060

GNF6702	Parasite	Infection
GNF6702 is a selective inhibitor of the kinetoplastid proteasome. GNF6702 clears parasites in murine models of leishmaniasis, Chagas disease, and human African trypanosomiasis .

HY-175741

IID432	Parasite Topoisomerase	Infection
IID432 is a Trypanosoma cruzi Topoisomerase II inhibitor with an EC₅₀ of 8  nM for Trypanosoma cruzi. IID432, a single dose of 25 mg/kg, can achieve relapse-free parasite clearance in mouse models of chronic Chagas disease. IID432 can be used for Chagas disease research .

HY-N12788

T-Cadinol	Parasite	Infection
T-Cadinol is a sesquiterpene isolated from C. sylvestris that exhibits anti-Trypanosoma cruzi activity, with IC₅₀ values of 18.2 μM and 15.8 μM against trypomastigote and amastigote forms, respectively. T-Cadinol can induce mitochondrial damage in parasites, leading to membrane hyperpolarization and decreased levels of reactive oxygen species. T-Cadinol can be used for the research of Chagas disease .

HY-N11173A

trans-Melilotoside	Parasite	Infection
trans-Melilotoside is a coumarin precursor and that can be isolated from Melilotus neapolitan. trans-Melilotoside exhibits antiparasitic and DPPH radical-scavenging activity. trans-Melilotoside can be used for the research of human african trypanosomiasis, chagas’ disease, malaria ^[1] ^[3].

HY-153238

AN15368	Parasite	Infection
AN15368 is an orally active small-molecule precursor that can be activated by parasite carboxypeptidase to produce a compound that targets the messenger RNA processing pathway in T. cruzi. cruzi. AN15368 has the potential to prevent and research Chagas disease potential .

HY-103033

T.cruzi-IN-1	Parasite	Infection
T.cruzi-IN-1 is a potent *Trypanosoma cruzi* inhibitor with an IC₅₀ of 8 nM. T.cruzi-IN-1, a 4-trifluoromethyl substituted analog, has the potential for both the acute and chronic stages of Chagas disease .

HY-N10443

Mammea A/BA	Parasite Apoptosis Autophagy Reactive Oxygen Species (ROS)	Infection
Mammea A/BA has potent activity against Trypanosoma cruzi (T. cruzi). Mammea A/BA induces mitochondrial dysfunction, reactive oxygen species (ROS) production and DNA fragmentation, and increases number of acidic vacuoles. Mammea A/BA can induce apoptosis, autophagy and necrosis. Mammea A/BA can be used for researching chagas disease .

HY-N3702

Dehydroabietinol	Syk	Infection Inflammation/Immunology
Dehydroabietinol is a SYK inhibitor with an IC₅₀ of 46.4 μM. Dehydroabietinol inhibits the growth of Trypanosoma cruzi epimastigotes, Leishmania braziliensis promastigotes and Leishmania infantum promastigotes. Dehydroabietinol indirectly inhibits the growth of Plasmodium falciparum, alters the erythrocyte membrane, and induces spherostomatocyte transformation and endovesicle formation. Dehydroabietinol can be used in studies related to immune-mediated diseases, Chagas disease, leishmaniasis and malaria .

HY-118338

WRR-483	Parasite	Infection
WRR-483 is an analog of K11777, an inhibitor of cruzain, used to inhibit the proliferation of Trypanosoma cruzi in cell culture. WRR-483 can eradicate parasitic infection in an acute Chagas disease mouse model. WRR-483 is an irreversible cysteine protease inhibitor that shows pH-dependent high affinity and potent trypanocidal activity against cruzain and T. cruzi infection, and is expected to inhibit Chagas disease.

HY-B1548R

Benznidazole (Standard) Benznidazol (Standard); Ro 07-1051 (Standard); Ro 71051 (Standard)	Reference Standards Parasite Antibiotic	Infection
Benznidazole (Standard) is the analytical standard of Benznidazole. This product is intended for research and analytical applications. Benznidazole (Ro 07-1051) is an antiparasitic medication, with an IC₅₀ of 20.35 μM for Colombian T. cruzi strains, and has been used in the treatment of Chagas disease .

HY-114763

LP8	Cytochrome P450 Parasite	Infection
LP8 is a Pyridinyl-type CYP51 inhibitor and can be used for study of chagas disease and American trypanosomiasis .

HY-117129

MK 436 MK-0436	Parasite	Infection
MK 436 (MK-0436) is a metabolite with anti-trypanosomal activity that can be isolated from dog urine, particularly effective against Trypanosoma cruzi, the pathogen responsible for Chagas disease in South America .

HY-173461

Anti-Trypanosoma cruzi agent-7	Parasite	Infection
Anti-Trypanosoma cruzi agent-7 (compound 1) is a potent Trypanosoma cruzi inhibitor with an EC₅₀ of 1.26 µM. Anti-Trypanosoma cruzi agent-7 can be used in the study of Chagas disease .

HY-129228

Lychnopholide	Parasite	Infection
Lychnopholide is a sesquiterpene lactone derived from the Asteraceae, Lychnopholide exhibits anti-trypanosomal activity against Trypanosoma cruzi. lychnopholide encapsulated in nanocapsules reduces its toxicity to mammalian cells. Lychnopholide ameliorates Chagas disease in mouse models .

HY-175305

DMU759	Parasite	Infection
DMU759 is a Lysyl-tRNA synthetase 1 (KRS1) inhibitor. DMU759 has potent anti-kinetoplastid activity against Trypanosoma cruzi , Trypanosoma brucei and Leishmania donovani. DMU759 significantly reduces parasitemia in acute Chagas disease mice model. DMU759 can be used for parasitic infection like Chagas disease research .

HY-155103

Antitrypanosomal agent 15	Proteasome Parasite	Infection
Antitrypanosomal agent 15 (compound 26) is an orally active, brain-penetrant, selective inhibitor against Trypanosoma cruzi proteasome, with an _pIC₅₀ of 7.4 and <4 for T. cruzi and human proteasome, respectively. Antitrypanosomal agent 15 has favorable ADME properties and can be used for Chagas disease study .

HY-155693

Topoisomerase II inhibitor 16	Topoisomerase Parasite	Infection
Topoisomerase II inhibitor 16 (compound CT3) is a selective, orally active, brain-penetrant and irreversible trypanosomal topoisomerase II inhibitor by stabilizing double-stranded DNA:enzyme cleavage complexes. Topoisomerase II inhibitor 16 has the potential for Chagas disease research .

HY-121187

BiPNQ	Parasite	Infection
BiPNQ is a potent inhibitor of Trypanosoma cruzi, the causative agent of Chagas disease .

HY-170782

CZP-IN-1	Casein Kinase	Infection
CZP-IN-1 (compound SH-1) is an inhibitor targeting the pathogen Trypanosoma cruzi cruzipain (CZP) and does not inhibit cathepsin L (IC₅₀=28 nM). CZP-IN-1 can be used for the research of Chagas disease .

HY-N15655

Ravenelin	Bacterial	Infection
Ravenelin is a xanthone that can be isolated from the endophytic fungus Exserohilum rostratum. Ravenelin exhibits antiprotozoal and antibacterial activity. Ravenelin is active against gram-positive bacterial strains. Ravenelin can be studied for hit-to-lead development, especially for Chagas Disease .

HY-B1548S

Benznidazole-d7 Benznidazol-d₇; Ro 07-1051-d₇; Ro 71051-d₇	Isotope-Labeled Compounds Parasite Antibiotic	Infection
Benznidazole-d₇ (Benznidazol-d₇; Ro 07-1051-d₇; Ro 71051-d₇) is the deuterium labeled Benznidazole (HY-B1548). Benznidazole (Ro 07-1051) is an antiparasitic medication, with an IC₅₀ of 20.35 μM for Colombian T. cruzi strains, and has been used in the treatment of Chagas disease .

HY-168001

TcNTPDase1-IN-1	NTPDase	Infection Cancer
TcNTPDase1-IN-1 (compound 16) is an inhibitor of nucleoside triphosphate diphosphohydrolase 1 (TcNTPDase1) from Trypanosoma cruzi in vitro. TcNTPDase1-IN-1 can be used in antibacterial, antitoxic and antitumor related research .

HY-159915

Se2h	Parasite	Infection
Se2h is a cruzain inhibitor that exhibits strong activity against the intracellular amastigotes of Trypanosoma cruzi (EC₅₀ < 1 μM, SI > 10), with an inhibitory activity against cruzain of IC₅₀ < 100 nM (SI > 5.55). Compared to Benznidazole (HY-B1548) and the cruzain inhibitor K777 (HY-119293), Se2h shows superior selectivity and inhibition, while its selenazole structure reduces selenium-related toxicity. Se2h exhibits antiparasitic activity and holds promise for research in Chagas disease .

HY-181508

Antitrypanosomal agent 30	Parasite	Infection
Antitrypanosomal agent 30 (compound 6b) is a trypanocidal agent with extremely low cytotoxicity against mouse macrophages. Antitrypanosomal agent 30 can be used for the research of Chagas disease .

HY-112453

IMDNQ1	Parasite	Infection
IMDNQ1 is a Trypanosoma cruzi inhibitor derived from 1,4-naphthoquinone substituted with cyclic imide. IMDNQ1 effectively inhibits the proliferation of Trypanosoma cruzi epimastigotes, while also reducing the viability of mouse fibroblasts. The selectivity index between the antiproliferative activity and cytotoxicity of IMDNQ1 is 60.25, indicating a certain level of safety. IMDNQ1 can be widely used in studies related to Chagas disease .

HY-182443

PEX5-PEX14 PPI-IN-4	Parasite	Infection
PEX5-PEX14 PPI-IN-4 is a potent PEX14-PEX5 PPI inhibitor, with EC₅₀ values of 7.78 μM, 27.5 μM and 9.31 μM against the protein-protein interactions of TbPEX14-PEX5, TcPEX14-PEX5 and HsPEX14-PEX5, respectively. PEX5-PEX14 PPI-IN-4 exhibits trypanocidal activity against Trypanosoma brucei rhodesiense and Trypanosoma cruzi. PEX5-PEX14 PPI-IN-4 shows cytotoxic activity against mammalian cells. PEX5-PEX14 PPI-IN-4 can be used in the research of human African trypanosomiasis and Chagas disease .

HY-W040126

Tn antigen GalNAcα-O-Ser	Parasite	Infection
Tn Antigen (Tn Epitope) (Compound 1) is a Trypanosoma cruzi trans-sialidase (TcTS) inhibitor with inhibition rate of 57% at 1 mM. Tn Antigen shows anti-trypanosomal activity with an IC₅₀ of >0.5 mM. Tn Antigen can be used for the research of Chagas’ disease .

HY-168732

MCG-02	Parasite	Infection
MCG-02 is the inhibitor for cruzain (CRZ) and cathepsin L-like protease (CATL), that inhibits the CRZ in Trypanosoma cruzi and CATL in Trypanosoma brucei with the IC₅₀ 0.2 μM and 0.02 μM .

HY-172206

TSO-13	Parasite	Infection
TSO-13 is the inhibitor for the main cysteine protease of Trypanosoma cruzi Cruzipain with an IC₅₀ of 2.2 μM. TSO-13 inhibits T. cruzi in Vero cell with an IC₅₀ of 1.9 μM .

HY-N19727

Chamissonolide	Interleukin Related IFNAR TNF Receptor Apoptosis	Infection Cancer
Chamissonolide is a sesquiterpene lactone with cytotoxic, anti-inflammatory and trypanocidal activities. Chamissonolide reduces the mRNA levels of IL-2, IFN-γ, GM-CSF, iNOS and TNF-α, and upregulates the mRNA level of NF-ATc. Chamissonolide decreases the population of naturally occurring apoptotic cells. Chamissonolide can be used in research related to tumors, African trypanosomiasis and Chagas disease .

HY-N17585

Lanost-8-ene-3b,22R,24S-triol	Others	Others
Lanost-8-ene-3b,22R,24S-triol (compound 7) is a lanostane-type triterpenoid. Lanost-8-ene-3b,22R,24S-triol can be found in the sclerotia of Inonotus obliquus (Alaskan chaga) .

HY-182516

Aminobutane bisphosphonate	Farnesyl Transferase	Infection Others
Aminobutane bisphosphonate is a Trypanosoma cruzi farnesyl pyrophosphate synthase (FPPS) inhibitor with an IC₅₀ of 30.77 μM against Trypanosoma cruzi. Aminobutane bisphosphonate inhibits proliferation of intracellular amastigote Trypanosoma cruzi and lacks activity against non-infective epimastigote forms. Aminobutane bisphosphonate reduces osteoclastic bone resorption, osteoid surface extent, and osteoclast number per mm of bone surface. Aminobutane bisphosphonate can be used for the research of american trypanosomiasis (chagas' disease) and immobilization-related bone loss .

HY-105111

P-536	Parasite Angiotensin-converting Enzyme (ACE) HSV DNA/RNA Synthesis	Cardiovascular Disease Metabolic Disease
P-536 is a ACE inhibitor that also inhibits herpes simplex virus HSV-1 thymidine kinase and Trypanosoma cruzi RNA polymerase. By inhibiting the renin-angiotensin system, downregulating the expression of AT1R and NOX4, and reducing oxidative stress (decreasing plasma hydrogen peroxide (H₂O₂) and 8-isoprostaglandin levels), P-536 effectively reduces systolic blood pressure and improves vascular reactivity. P-536 also inhibits the replication of DNA/RNA viruses such as HSV-1 by blocking nucleotide metabolism and nucleic acid synthesis, competitively inhibits RNA synthesis in Trypanosoma cruzi, and inhibits amastigote replication, thereby impeding its growth. P-536 is suitable for research on hypertension, insulin resistance, and Chagas disease .

HY-183747

Antitrypanosomal agent 32	Parasite	Infection
Antitrypanosomal agent 32 is a antitrypanosomal agent with nanomolar potency against multiple Trypanosoma cruzi strains, including CL-Brener, Y, Dm28c-Luc and Tulahuen. Antitrypanosomal agent 32 sustains inhibition of parasite growth after washing and reduces parasitemia levels in BALB/c mice. Antitrypanosomal agent 32 can be used for the research of trypanosome infection .

HY-185309

Anti-Trypanosoma cruzi agent-9	Topoisomerase Parasite	Infection
Anti-Trypanosoma cruzi agent-9 is a topoisomerase II inhibitor. Anti-Trypanosoma cruzi agent-9 inhibits the growth of Trypanosoma cruzi and Leishmania donovani .

HY-181516

Anti-Trypanosoma cruzi agent-8	Parasite	Infection
Anti-Trypanosoma cruzi agent-8 is an anti-*Trypanosoma* agent and also a Trypanosoma cruzi trypanothione reductase (TcTR) inhibitor, with an IC₅₀ of 3.9 μM against TcTR. Anti-Trypanosoma cruzi agent-8 functionally inhibits the enzymatic activity of TcTR. Anti-Trypanosoma cruzi agent-8 exhibits trypanocidal activity against intracellular Trypanosoma cruzi amastigotes .

Cat. No.	Product Name	Category	Target	Chemical Structure